药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
1-Androstenedione
Isavuconazole
The serum concentration of Velpatasvir can be increased when it is combined with Isavuconazole.
1-Androstenedione
Pitolisant
The serum concentration of Velpatasvir can be decreased when it is combined with Pitolisant.
1-Androstenedione
Apalutamide
The serum concentration of Velpatasvir can be decreased when it is combined with Apalutamide.
1-Androstenedione
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Velpatasvir.
1-Androstenedione
Mometasone furoate
The metabolism of Velpatasvir can be decreased when combined with Mometasone furoate.
1-Androstenedione
Fluticasone
The metabolism of Velpatasvir can be decreased when combined with Fluticasone.
1-Androstenedione
Trametinib
The metabolism of Velpatasvir can be decreased when combined with Trametinib.
1-Androstenedione
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Velpatasvir.
19-Nor-4-androstenedione
Lefamulin
Lefamulin may increase the QTc-prolonging activities of Bilastine.
19-Nor-4-androstenedione
Entrectinib
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Entrectinib.
19-Nor-4-androstenedione
Deoxyepinephrine
The therapeutic efficacy of Deoxyepinephrine can be increased when used in combination with Bilastine.
19-Nor-4-androstenedione
Theodrenaline
The therapeutic efficacy of Theodrenaline can be increased when used in combination with Bilastine.
19-Nor-4-androstenedione
Racepinephrine
The therapeutic efficacy of Racepinephrine can be increased when used in combination with Bilastine.
19-Nor-4-androstenedione
Protokylol
The therapeutic efficacy of Protokylol can be increased when used in combination with Bilastine.
19-Nor-4-androstenedione
Levonordefrin
The therapeutic efficacy of Levonordefrin can be increased when used in combination with Bilastine.
19-Nor-4-androstenedione
Relugolix
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Relugolix.
19-Nor-4-androstenedione
Fostemsavir
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Fostemsavir.
19-Nor-4-androstenedione
Inotersen
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Inotersen.
19-Nor-4-androstenedione
Aripiprazole lauroxil
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Aripiprazole lauroxil.
19-Nor-4-androstenedione
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Pipemidic acid.